The International Neuro-Oncology Summit in Geneva was not merely a conference; it was a coronation. It was held in a gleaming glass-and-steel monolith overlooking the lake, a temple dedicated to the gods of medicine and money. The air inside hummed with a hushed reverence, thick with the scent of expensive perfume and a particular kind of intellectual ambition that was both inspiring and terrifying.
I was there not as a keynote speaker or a celebrated researcher, but as part of the Apex Bio delegation. My official title was Senior Research Analyst, a deliberately vague and unassuming label that allowed me to move through the crowds without drawing attention. I was a ghost at the feast, a silent observer sent to watch a controlled demolition from the inside.
On the opening night, at the w
